Neuroscience

AAN issues evidence-in-focus article on aducanumab

To help neurologists, patients and their families understand the current evidence on the use of aducanumab to treat Alzheimer's disease, the American Academy of Neurology (AAN) has issued an evidence-in-focus article, published ...

Vaccination

Moderna plans 100 million Covid vaccine doses in early 2021

Moderna plans to have 100 to 125 million doses of its COVID-19 vaccine available in the first quarter of 2021, the vast majority of which will go to the United States, the biotechnology company announced Thursday.

Medications

More than 2 dozen drugmakers to make Merck's COVID-19 pill

A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck's COVID-19 pill to supply 105 developing countries.

Oncology & Cancer

New database to 'SpUR' on cancer research

An interactive web portal developed by scientists at KAUST offers a platform for cancer researchers to interrogate how RNA splicing in noncoding parts of genes fuels the growth of different types of tumors.

page 25 from 40